MGIA
HAE icon

Moneta Group Investment Advisors’s Haemonetics HAE Stock Holding History

Moneta Group Investment Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-389
Closed -$13K – 254
2015
Q3 		$13K Buy
+389
New +$14.6K ﹤0.01% 383

Other funds holding HAE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Moneta Group Investment Advisors's HAE Position: Q4 2015 in Review

Moneta Group Investment Advisors sold out of Haemonetics (HAE) in Q4 2015, closing a stake of 389 shares — an estimated $13K sold.

Moneta Group Investment Advisors first reported a position in HAE in Q3 2015 and held it in 1 quarter. The position peaked at $13K in Q3 2015. 163 funds tracked by Wall St. Rank hold HAE as of Q4 2015.

  • Moneta Group Investment Advisors reported no remaining Haemonetics position as of Q4 2015 after selling out during the quarter.
  • Moneta Group Investment Advisors sold 389 Haemonetics shares in Q4 2015, an estimated $13K.
  • Moneta Group Investment Advisors first reported a position in Haemonetics in Q3 2015 and held it in 1 quarter.
  • Moneta Group Investment Advisors's Haemonetics position peaked at $13K in Q3 2015.
  • 163 funds tracked by Wall St. Rank held Haemonetics as of Q4 2015.

Based on Moneta Group Investment Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.